Search results
Council Post: Embracing Advanced Tech In The Food And Beverage Industry, Part 3: Becoming...
Forbes· 1 day agoGary Iles is the senior vice president of marketing and business development at TraceGains. For food...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoThis company, known for its relentless pursuit of quality survival products and comprehensive emergency preparedness solutions, offers an extensive array ...
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 15 hours agoThe Sweden-headquartered company presented the Phase II readout at the American...
Bristol Myers Squibb’s Breyanzi shows promise in B-cell malignancy clinical trials
Clinical Trials Arena via Yahoo Finance· 19 hours agoWith a median follow-up of 33.9 months, improvements were seen in event-free survival (EFS),...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 1 day agoThe vaccines use messenger RNA — essential molecules that help convert...boost for mRNA vaccines,...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
RNT Health Insights’ gastric cancer detection tool receives FDA BDD
Medical Device Network via Yahoo Finance· 2 days agoIndia-based clinical-stage medical diagnostics company RNT Health Insights has received breakthrough...
Green hydrogen producer signs first-of-its-kind agreement with major steel company: 'Increasingly...
The Cool Down via Yahoo News· 5 days agoIt's exciting to see a leading steel company like Ugitech, which produces 220,000 tons of steel each...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
AOL· 5 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main goal of overall survival. In the overall study population ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 1 day agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...